Clinical trials for cancer treatment
AI-powered clinical trial matching for your oncology patients
Instantly identify actively recruiting trials for Follicular Lymphoma, Multiple Myeloma, and Breast Cancer—personalized to your patient’s diagnosis and treatment history.
Start your search today
Sign up for CancerBot today and start matching your patients to trials that actually fit.
Clinical trials for cancer treatment
AI-powered clinical trial matching for your oncology patients
Instantly identify actively recruiting trials for Follicular Lymphoma, Multiple Myeloma, and Breast Cancer—personalized to your patient’s diagnosis and treatment history.
Start your search today
Sign up for free, share your treatment details and get matched with potential trials in minutes.
Clinical trials for cancer treatment
AI-powered clinical trial matching for your oncology patients
Instantly identify actively recruiting trials for Follicular Lymphoma, Multiple Myeloma, and Breast Cancer—personalized to your patient’s diagnosis and treatment history.
Start your search today
Sign up for free, share your treatment details and get matched with potential trials in minutes.
Your patients deserve every option. Finding them shouldn’t slow you down.
Cancer care is getting more complex. Clinical trials shouldn’t be harder to find
than the disease itself.
CancerBot helps physicians quickly identify relevant, actively recruiting clinical trials for their patients — without spending hours navigating ClinicalTrials.gov or relying on incomplete referral networks.
Built for the way physicians actually work
Whether you’re a GP, community oncologist, or academic specialist, CancerBot fits naturally into your workflow. Just clear, precise matches — tailored to your patient.
No trial-hunting
No eligibility guesswork
No endless PDFs
Who CancerBot Is For
General Practitioners
You’re often the first point of contact
You want to know when a trial might be appropriate
You don’t have time to read full protocols
CancerBot helps you identify when a patient should be referred — and where.
Oncologists & Hematologists
You manage FL, MM, and BC across multiple lines of therapy
Trials are increasingly biomarker-driven and complex
Missing the right trial can mean missing the best option
CancerBot surfaces trials you’d never find through keyword search alone.
Why CancerBot is different
Why CancerBot is different
Most trial finders rely on keywords. CancerBot understands biology, eligibility logic, and treatment history. CancerBot matches patients based on:
Most trial finders rely on keywords. CancerBot understands biology, eligibility logic, and treatment history. CancerBot matches patients based on:
Disease subtype (e.g. FL vs transformed disease)
Disease subtype
(e.g. FL vs transformed disease)
Line of therapy
Line of therapy
Prior treatments and refractoriness
Prior treatments and refractoriness
Biomarkers and lab thresholds
Biomarkers and lab thresholds
Trial intent (front-line, relapse, refractory)
Trial intent (front-line, relapse, refractory)
The result: fewer false matches, fewer dead ends, and faster decisions.
The result: fewer false matches, fewer dead ends, and faster decisions.
Focused on high-impact diseases
CancerBot currently prioritizes:
Follicular Lymphoma (FL)
Follicular Lymphoma (FL)
Bispecific antibodies
Novel combinations
Post-anti-CD20 / post-CAR-T options
Bispecific antibodies
Novel combinations
Post-anti-CD20 / post-CAR-T options
Multiple Myeloma (MM)
Multiple Myeloma (MM)
CAR-T (single & dual-target)
Bispecifics
Early-line and heavily pretreated trials
CAR-T (single & dual-target)
Bispecifics
Early-line and heavily pretreated trials
Breast Cancer (BC)
Breast Cancer (BC)
Biomarker-driven studies
Subtype-specific trials
Precision oncology approaches
Biomarker-driven studies
Subtype-specific trials
Precision oncology approaches
Why this matters for patients
Why this matters for patients
Many eligible patients never enroll in a clinical trial — not because trials don’t exist, but because:
Many eligible patients never enroll in a clinical trial — not because trials don’t exist, but because:
The right trial wasn’t found in time
The right trial wasn’t found in time
Eligibility was too complex to assess quickly
Eligibility was too complex to assess quickly
The trial was outside the clinician’s immediate network
The trial was outside the clinician’s immediate network
CancerBot closes that gap.
CancerBot closes that gap.
What you get when you sign up
What you get when
you sign up
Most trial finders rely on keywords. CancerBot understands biology, eligibility logic, and treatment history. CancerBot matches patients based on:
Most trial finders rely on keywords. CancerBot understands biology, eligibility logic, and treatment history. CancerBot matches patients based on:
Curated, actively recruiting trials
Curated, actively recruiting trials
Clear eligibility summaries
Clear eligibility summaries
Reduced screening burden
Reduced screening burden
Faster referrals
Faster referrals
Better options for complex cases
Better options for complex cases
All without changing how you practice medicine.
All without changing how you practice medicine.
Designed for trust, built for scale
No ads. No trial “promotion.” Just relevance and accuracy. CancerBot is designed with:
Designed for trust, built for scale
No ads. No trial “promotion.” Just relevance and accuracy. CancerBot is designed with:
Designed for trust, built for scale
No ads. No trial “promotion.” Just relevance and accuracy. CancerBot is designed with:
About CancerBot
Turning frustration into innovation
After being diagnosed with follicular lymphoma, AI tech entrepreneur Adam Blum assumed he could easily find cutting-edge treatment options. Instead, he faced resistance from doctors and an exhausting search process. Determined to fix this, he built CancerBot—an AI-powered tool that makes clinical trials more accessible, helping patients find potential life-saving treatments faster.
About CancerBot
Turning frustration into innovation
After being diagnosed with follicular lymphoma, AI tech entrepreneur Adam Blum assumed he could easily find cutting-edge treatment options. Instead, he faced resistance from doctors and an exhausting search process. Determined to fix this, he built CancerBot—an AI-powered tool that makes clinical trials more accessible, helping patients find potential life-saving treatments faster.
About CancerBot
Turning frustration into innovation
After being diagnosed with follicular lymphoma, AI tech entrepreneur Adam Blum assumed he could easily find cutting-edge treatment options. Instead, he faced resistance from doctors and an exhausting search process. Determined to fix this, he built CancerBot—an AI-powered tool that makes clinical trials more accessible, helping patients find potential life-saving treatments faster.
Help your patients access better options
Sign up for CancerBot today and start matching your patients to trials that actually fit.
Help your patients access better options
Sign up for CancerBot today and start matching your patients to trials that actually fit.
Help your patients access better options
Sign up for CancerBot today and start matching your patients to trials that actually fit.